China Fertility Services Market Research Report - Forecast till 2027

China Fertility Services Market Research Report: by Underlying Cause (Female Infertility, Male Infertility), by Treatment Type (Assistive Reproductive Technology (ART), Infertility Drugs), by End-user (Fertility Clinics, Clinical Research Institutes, Hospitals, Others) and Region - Forecast till 2027

ID: MRFR/HC/5690-HCR | February 2021 | Region: Bric | 70 pages

China Fertility Services Market Overview


Crises regarding the booming population in China are in the process of getting neutralized. But the process has revealed some starkly contradictory pictures regarding infertility. Infertility in China is on the rise, and it has raised many eyebrows. China’s emergence as a powerful economy has caused a paradigmatic shift in the lifestyle, which has promoted a sedentary lifestyle and altered the dietary consumption pattern. In addition, climate-related issues are spelling doom for many. Stresses in life and increasing alcohol consumption can also be credited for creating such mayhem in hormonal balance. These have impacted the fertility rate considerably. It has thwarted China’s plan to have a baby boom. The sperm banks are also facing a shortage.


Indirectly, this problem has stirred quite a few feathers among the policymakers. They have realized that the country can soon face a labor shortage and increasing healthcare demands among the aging population can disrupt the smooth workflow of the government. Independent research institutes and government have realized that the introduction of fertility-related measures has to be taken seriously which has triggered a growth in the fertility services market. The China fertility services market is eyeing for substantial growth during the forecast period (2019-2024). The report published by Market Research Future (MRFR) has insightful details of the segments and analysis of influencers to impact the market in the coming years. At the same time, it also has expert views on the said market for a holistic understanding.


Among the major factors bolstering the China fertility services market, integration of advanced technologies such as in vitro fertilization (IVF) procedures in the healthcare sector and reimbursement schemes introduced by various organizations can become effective in raising the valuation of the market in the coming years. At the same time, fertility tourism in China is having a great run which can substantially boost the regional fertility services market.


Segmentation:


By underlying cause, the China fertility services market can be segmented into female fertility and male infertility. Based on the treatment type, the China fertility services market can be segmented into assistive reproductive technology (ART) and infertility drugs. Based on the end-users, the China fertility market comprises fertility clinics, clinical research institutes, hospitals, and others.


Regional Analysis


The China fertility services market covers the latest trends and events across East China, West China, Central China, Southeast China, and North China. China is fast emerging as a destination for fertility treatment. It is undergoing changes in both government regulations and healthcare structure to emerge as a fertility tourism destination. The initial results are quite astounding. In particular, East China is doing an extraordinary job where the region is witnessing in a surge of patients from not just in China but across the world.


Key Competitors:


Prominent industry participants in the China fertility services market include Merck KGaA, Cooper Surgical, Ferring Pharmaceuticals, Irvine Scientific Sales Company, Inc., Cook Medical, and Vitrolife. Mergers, acquisitions, and new products launches are prime strategies to gain a firm hold in the market.


Research Methodology:


This research study makes the complexities of the global bioreactors market clear and easy to understand through the use of powerful analytical tools to break down the data into directly utilizable data points. The data is scoured from primary interviews backed by reliable secondary research, resulting in the creation of a highly accurate, tested information repository. The hierarchy in the global bioreactors market is thoroughly researched to give investors a brief idea to break into the market and make the most of your incursion. The best angles of attack for all size of industry players are enumerated in the report. The document is a must-have accessory for all players looking to capitalize on the medical industry boom.


China Fertility Services Market by Underlying Cause



  • Male Infertility

  • Female Infertility


China Fertility Services Market by Treatment Type



  • Assistive Reproductive Technology (ART)

  • Infertility Drugs


China Fertility Services Market by End-user



  • Hospitals

  • Fertility Clinics

  • Clinical Research Institutes

  • Others


China fertility services market by Region



  • North China

  • East China

  • West China

  • Southeast China

  • Central China



Speak to Analyst Ask for Customization


This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.